Induction of MIF synthesis and secretion by tubular epithelial cells: A novel action of angiotensin II

Kidney International

Volumn 63, Issue 4, 2003, Pages 1265-1275

  Rice, Edwina K ^a   Tesch, Gregory H ^b   Cao, Zemin ^b   Cooper, Mark E ^b   Metz, Christine N ^b   Bucala, Richard ^b   Atkins, Robert C ^b   Nikolic Paterson, David J ^b  

^a MONASH MEDICAL CENTRE   (Australia)

^b NONE

Author keywords

Angiotensin; MIF; Subtotal nephrectomy

Indexed keywords

ANGIOTENSIN; IRBESARTAN; MACROPHAGE MIGRATION INHIBITION FACTOR; MESSENGER RNA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; GLOMERULUS EPITHELIUM; IN VITRO STUDY; KIDNEY CORTEX; KIDNEY INTERSTITIUM; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; KIDNEY TUBULE EPITHELIUM; MACROPHAGE MIGRATION; NEPHRECTOMY; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN SECRETION; PROTEIN SYNTHESIS; RAT; UPREGULATION;

EID: 0037377656     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2003.00875.x     Document Type: Article

References (59)

1. LEWIS EJ, HUNSICKER LG, BAIN RP, et al: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 329:1456-1462, 1993
2. LEWIS EJ, HUNSICKER LG, CLARKE WR, et al: Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 345:851-860, 2001
3. MASCHIO G, ALBERTI D, JANIN G, et al: Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N Engl J Med 334:939-945, 1996
4. THE GISEN GROUP (GRUPPO ITALIANO DI STUDI EPIDEMIOLOGICI IN NEFROLOGIA): Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric: Non-diabetic nephropathy. Lancet 349:1857-1863, 1997
5. KAGAMI S, BORDER WA, MILLER DE, et al: Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J Clin Invest 93:2431-2437, 1994
6. NAKAMURA A, JOHNS EJ, IMAIZUMI A, et al: Effect of beta (2)-adrenoceptor activation and angiotensin II on tumour necrosis factor and interleukin 6 gene transcription in the rat renal resident macrophage cells. Cytokine 11:759-765, 1999
7. HERNANDEZ-PRESA M, BUSTOS C, ORTEGO M, et al: Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. Circulation 95:1532-1541, 1997
8. RUIZ-ORTEGA M, BUSTOS C, HERNANDEZ-PRESA MA, et al: Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 synthesis. J Immunol 161:430-439, 1998
9. CHEN XL, TUMMALA PE, OLBRYCH MT, et al: Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells. Circ Res 83:952-959, 1998
10. WOLF G, ZIYADEH FN, THAISS F, et al: Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells. Role of the angiotensin type 2 receptor. J Clin Invest 100:1047-1058, 1997
11. GRAFE M, AUCH-SCHWELK W, ZAKRZEWICZ A, et al: Angiotensin II-induced leukocyte adhesion on human coronary endothelial cells is mediated by E-selectin. Circ Res 81:804-811, 1997
12. TAYEH MA, SCICLI AG: Angiotensin II and bradykinin regulate the expression of P-selectin on the surface of endothelial cells in culture. Proc Assoc Am Physicians 110:412-421, 1998
13. PASTORE L, TESSITORE A, MARTINOTTI S, et al: Angiotensin II stimulates intercellular adhesion molecule-1 (ICAM-1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo. Circulation 100:1646-1652, 1999
14. TUMMALA PE, CHEN XL, SUNDELL CL, et al: Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculature: A potential link between the renin-angiotensin system and atherosclerosis. Circulation 100:1223-1229, 1999
15. PIQUERAS L, KUBES P, ALVAREZ A, et al: Angiotensin II induces leukocyte-endothelial cell interactions in vivo via AT(1) and AT(2) receptor-mediated P-selectin upregulation. Circulation 102:2118-2123, 2000
16. RUIZ-ORTEGA M, GONZALEZ S, SERON D, et al: ACE inhibition reduces proteinuria, glomerular lesions and extracellular matrix production in a normotensive rat model of immune complex nephritis. Kidney Int 48:1778-1791, 1995
17. SUZUKI Y, SHIRATO I, OKUMURA K, et al: Distinct contribution of Fc receptors and angiotensin II-dependent pathways in anti-GBM glomerulonephritis. Kidney Int 54:1166-1174, 1998
18. HISADA Y, SUGAYA T, YAMANOUCHI M, et al: Angiotensin II plays a pathogenic role in immune-mediated renal injury in mice. J Clin Invest 103:627-635, 1999
19. HOOKE DH, GEE DC, ATKINS RC: Leukocyte analysis using monoclonal antibodies in human glomerulonephritis. Kidney Int 31:964-972, 1987
20. LAN HY, YANG N, NIKOLIC-PATERSON DJ, et al: Expression of macrophage migration inhibitory factor in human glomerulonephritis. Kidney Int 57:499-509, 2000
21. DAVID JR: Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci USA 56:72-77, 1966
22. BLOOM BR, BENNETT B: Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 153:80-82, 1966
23. BERNHAGEN J, CALANDRA T, MITCHELL RA, et al: MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 365:756-759, 1993
24. BACHER M, METZ CN, CALANDRA T, et al: An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci USA 93:7849-7854, 1996
25. WISTOW GJ, SHAUGHNESSY MP, LEE DC, et al: A macrophage migration inhibitory factor is expressed in the differentiating cells of the eye lens. Proc Natl Acad Sci USA 90:1272-1275, 1993
26. CHESNEY J, METZ C, BACHER M, et al: An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma. Mol Med 5:181-191, 1999
27. LAN HY, YANG N, BROWN FG, et al: Macrophage migration inhibitory factor expression in human renal allograft rejection. Transplantation 66:1465-1471, 1998
28. LAN HY, MU W, YANG N, et al: De novo renal expression of macrophage migration inhibitory factor during the development of rat crescentic glomerulonephritis. Am J Pathol 149:1119-1127, 1996
29. LAN HY, BACHER M, YANG N, et al: The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat. J Exp Med 185:1455-1465, 1997
30. YANG N, NIKOLIC-PATERSON DJ, NG YY, et al: Reversal of established rat crescentic glomerulonephritis by blockade of macrophage migration inhibitory factor (MIF): Potential role of MIF in regulating glucocorticoid production. Mol Med 4:413-424, 1998
31. CAO Z, COX A, BONNET F: Increased osteopontin expression following renal ablation is attenuated by angiotensin type 1 receptor antagonism. Exp Nephrol 10:19-25, 2002
32. DIJKSTRA CD, DOPP EA, JOLING P, et al: The heterogeneity of mononuclear phagocytes in lymphoid organs: Distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology 54:589-599, 1985
33. WILLIAMS AF, GALFRE G, MILSTEIN C: Analysis of cell surfaces by xenogeneic myeloma-hybrid antibodies: Differentiation antigens of rat lymphocytes. Cell 12:663-673, 1977
34. BRIDEAU RJ, CARTER PB, MCMASTER WR, et al: Two subsets of rat T lymphocytes defined with monoclonal antibodies. Eur J Immunol 10:609-615, 1980
35. LAN HY, MU W, NG YY, et al: A simple, reliable, and sensitive method for nonradioactive in situ hybridization: Use of microwave heating to improve hybridization efficiency and preserve tissue morphology. J Histochem Cytochem 44:281-287, 1996
36. LAN HY, MU W, NIKOLIC-PATERSON DJ, et al: A novel, simple, reliable, and sensitive method for multiple immunoenzyme staining: Use of microwave oven heating to block antibody crossreactivity and retrieve antigens. J Histochem Cytochem 43:97-102, 1995
37. HAVERTY TP, KELLY CJ, HINES WH, et al: Characterization of a renal tubular epithelial cell line which secretes the autologous target antigen of autoimmune experimental interstitial nephritis. J Cell Biol 107:1359-1368, 1988
38. TESCH GH, NIKOLIC-PATERSON DJ, METZ CN, et al: Rat mesangial cells express macrophage migration inhibitory factor in vitro and in vivo. J Am Soc Nephrol 9:417-424, 1998
39. WEINSTOCK JV, BLUM AM, KASSAB JT: Angiotensin II is chemotactic for a T-cell subset which can express migration inhibition factor activity in murine schistosomiasis mansoni. Cell Immunol 107:180-187, 1987
40. NATARAJ C, OLIVERIO MI, MANNON RB, et al: Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway. J Clin Invest 104:1693-1701, 1999
41. YANG N, WU LL, NIKOLIC-PATERSON DJ, et al: Local macrophage and myofibroblast proliferation in progressive renal injury in the rat remnant kidney. Nephrol Dial Transplant 13:1967-1974, 1998
42. FUJIHARA CK, MALHEIROS DM, ZATZ R, et al: Mycophenolate mofetil attenuates renal injury in the rat remnant kidney. Kidney Int 54:1510-1519, 1998
43. LAFAYETTE RA, MAYER G, PARK SK, et al: Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. J Clin Invest 90:766-771, 1992
44. POLLOCK DM, DIVISH BJ, POLAKOWSKI JS, et al: Angiotensin II receptor blockade improves renal function in rats with reduced renal mass. J Pharmacol Exp Ther 267:657-663, 1993
45. OTS M, MACKENZIE HS, TROY JL, et al: Effects of combination therapy with enalapril and losartan on the rate of progression of renal injury in rats with 5/6 renal mass ablation. J Am Soc Nephrol 9:224-230, 1998
46. MACKIE FE, CAMPBELL DJ, MEYER TW: Intrarenal angiotensin and bradykinin peptide levels in the remnant kidney model of renal insufficiency. Kidney Int 59:1458-1465, 2001
47. GUAN S, FOX J, MITCHELL KD, et al: Angiotensin and angiotensin converting enzyme tissue levels in two-kidney, one clip hypertensive rats. Hypertension 20:763-767, 1992
48. VON THUN AM, VARI RC, EL-DAHR SS, et al: Augmentation of intrarenal angiotensin II levels by chronic angiotensin II infusion. Am J Physiol 266:F120-F128, 1994
49. MITCHELL KD, JACINTO SM, MULLINS JJ: Proximal tubular fluid, kidney, and plasma levels of angiotensin II in hypertensive ren-2 transgenic rats. Am J Physiol 273:F246-F253, 1997
50. BROWN FG, NIKOLIC-PATERSON DJ, HILL PA, et al: Urine macrophage migration inhibitory factor reflects the severity of renal injury in human glomerulonephritis. J Am Soc Nephrol 13:S7-S13, 2002
51. BROWN FG, NIKOLIC-PATERSON DJ, CHADBAN SJ, et al: Urine macrophage migration inhibitory factor concentrations as a diagnostic tool in human renal allograft rejection. Transplantation 71:1777-1783, 2001
52. TAAL MW, ZANDI-NEJAD K, WEENING B, et al: Proinflammatory gene expression and macrophage recruitment in the rat remnant kidney. Kidney Int 58:1664-1676, 2000
53. SCHILLER B, MORAN J: Focal glomerulosclerosis in the remnant kidney model - An inflammatory disease mediated by cytokines. Nephrol Dial Transplant 12:430-437, 1997
54. Yu XQ, Wu LL, HUANG XR, et al: Osteopontin expression in progressive renal injury in remnant kidney: Role of angiotensin II. Kidney Int 58:1469-1480, 2000
55. RICARDO SD, LEVINSON ME, DEJOSEPH MR, et al: Expression of adhesion molecules in rat renal cortex during experimental hydronephrosis. Kidney Int 50:2002-2010, 1996
56. KIM YG, HUANG XR, SUGA S, et al: Involvement of macrophage migration inhibitory factor (MIF) in experimental uric acid nephropathy. Mol Med 6:837-848, 2000
57. MIYAZAKI K, ISBEL NM, LAN HY, et al: Up-regulation of macrophage colony-stimulating factor (M-CSF) and migration inhibitory factor (MIF) expression and monocyte recruitment during lipidinduced glomerular injury in the exogenous hypercholesterolaemic (ExHC) rat. Clin Exp Immunol 108:318-323, 1997
58. LAN HY, YANG N, METZ C, et al: TNF-alpha up-regulates renal MIF expression in rat crescentic glomerulonephritis. Mol Med 3:136-144, 1997
59. BUSCHE S, GALLINAT S, FLEEGAL MA, et al: Novel role of macrophage migration inhibitory factor in angiotensin II regulation of neuromodulation in rat brain. Endocrinology 142:4623-4630, 2001